Admission Date:  [**2158-6-10**]              Discharge Date:   [**2158-6-13**]   Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**Doctor First Name 2080**] Chief Complaint: Hypotension, lethargy  Major Surgical or Invasive Procedure: None  History of Present Illness: [**Age over 90 **] year old male with history of metastatic esophageal adenocarcinoma (recently diagnosed, s/p GEJ stenting [**2158-6-6**]), partial colectomy for transverse colon adenocarcinoma ([**2154**]), restless leg syndrome, GERD who presents with hypotension.
The patient received Vancomycin/Zosyn empirically and Tylenol for his fever.
Troponin 0.02.
CT head unremarkable, CT torso given endorsement of diarrhea and abdominal pain was unremarkable.
CXR suggestive of possible biateral mid-lung field opacifications so the patient also received Levaquin 750mg IV X1.
The patient does not use oxygen at baseline.
ROS: Denies fever, chills, headache, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria.
Past Medical History: * Metastatic esophageal adenocarcinoma * Partial colectomy for transverse colon adenocarcinoma (T3, NO [**2154-6-14**]) * Restless legs syndrome * GERD * Postoperative atrial fibrillation * Cdiff colitis ([**2154-6-14**])   Social History: Lives with wife at home, married for 65-68 years.
Note is made of a bovine aortic arch with common origin of the innominate and left common carotid arteries.
The patient is status post transverse colectomy and surgical clips are seen in the right mid abdomen.
CT OF THE PELVIS WITH CONTRAST: A Foley catheter is seen within a decompressed bladder.
Narrowing of the distal esophageal stent compatible with known malignancy, and proximal dilatation of the esophagus filled with fluid.
A 23mm x 120mm [**Company 2267**] Ultraflex Covered Esophageal metal stent was placed across the mass successfully.
REF:  1421  LOT:  [**Numeric Identifier 26960**] Recommendations: Follow-up with Dr. [**Last Name (STitle) **] Omeprazole 40mg by mouth twice daily Full liquids for 72 hours, then may advance to soft diet  CT torso with contrast ([**Hospital1 18**] [**Location (un) 620**], [**2158-5-25**]): FOCAL ESOPHAGEAL/GASTRIC MURAL THICKENING AND STRANDING WITH AT           LEAST ONE SMALL PARAESOPHAGEAL LYMPH NODE, AT THE           GASTROESOPHAGEAL JUNCTION.
MULTIPLE SCLEROTIC AND LUCENT BONE LESIONS CONCERNING FOR           METASTATIC DISEASE NEW SINCE THE STUDY OF [**2154-6-20**].
TINY           HYPODENSE RENAL LESIONS ARE TOO SMALL TO CHARACTERIZE AND IF           SOURCE OF MALIGNANCY IS UNKNOWN AND FURTHER CHARACTERIZATION, PARTICULARLY OF THE RIGHT LOWER POLE LESION IS ESSENTIAL, THEN AN ULTRASOUND COULD BE PERFORMED INITIALLY.
Brief Hospital Course: Assessment and Plan: [**Age over 90 **] year old male with history of metastatic esophageal adenocarcinoma (recently diagnosed, s/p GEJ stenting [**2158-6-6**]) called out of the MICU with GNR sepsis.
Blood pressures improved with IVF resusucitation and patient did not require pressors.
WBC downtrended with addition of IV antibiotics.
Pt received 2 days of Zosyn, 2 days of ertapenem, and was discharged with 3 days of oral cefpodoxime (once speciation returned as E. coli sensitive to Ertapenem) for a total of 7 days of treatment for bacteremia/sepsis.
A discussion was held with the family and they were told the patient could not go home on hospice with IV antibiotics so the decision was made to pull his midline and send him home on three days of oral antibiotics.
# Metastatic esophageal adenocarcinoma: s/p GEJ stenting earlier this week with extensive malignancy noted on EGD and likely has metastases in retroperitoneal lymph nodes and the bones.
Changed omeprazole to lansoprazole on discharge given dysphagia since he was having difficulty swallowing pills.
# h/o prostate cancer: Metastatic, continue home flutaide and leuprolide q3months.
Added liquid oxycodone for pain control  given going home on hospice.
#FEN: mechanical soft diet, replete electrolytes prn #PPX: heparin sq #Code: DNR/DNI #Communication: wife [**First Name8 (NamePattern2) **] [**Name (NI) 7356**], HCP [**Telephone/Fax (1) 26962**]), son.
[**First Name8 (NamePattern2) **] [**Name8 (MD) **] MD [**Last Name (Titles) 4207**]-3 [**Pager number 26963**] Current Clinical Status:afebrile   Medications on Admission: * Flutamide 125mg daily * Leuprolide 3.75mg every three months * Omeprazole 40mg twice daily * Pramipexole 0.25mg daily * Docusate 100mg daily * Multivitamin daily   Discharge Medications: 1. lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Disp:*30 packets* Refills:*0* 3. docusate sodium 100 mg Capsule [**Last Name (STitle) **]: One (1) Capsule PO BID (2 times a day) as needed for constipation.
Disp:*30 Capsule(s)* Refills:*0* 4. senna 8.6 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO BID (2 times a day): hold for loose stools.
5. pramipexole 0.25 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO daily  ().
6. oxycodone 5 mg/5 mL Solution [**Last Name (STitle) **]: Five (5) mg PO Q4H (every 4 hours) as needed for pain, anxiety, restless leg.
8. ertapenem 1 gram Recon Soln [**Last Name (STitle) **]: One (1) gram Intravenous once a day for 3 days.
Disp:*3 grams* Refills:*0* 9. leuprolide 3.75 mg Kit [**Last Name (STitle) **]: One (1) injection Intramuscular q3months.
Hospice Please provide Hospice Consult 11. cefpodoxime 200 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO twice a day for 3 days.
You required a brief stay in the ICU due to low blood pressures, where you were given fluids and IV antibiotics.
Your blood pressure improved and you were discharged on oral antibiotics for three more days to complete one full week to treat your infection.
Take Cefpodoxime 200 mg by mouth twice a day for three days (start date is [**2158-6-14**], last day is [**2158-6-16**].)
Please discuss discontinuing your prostate cancer medications with your hospice team and your primary care physician/oncologist.
